April 10, 2024 Preclinical PD-1 Resistance Models: Crucial Tools for Unveiling PD-1 Resistance Mechanisms and Advancing Novel Treatment Strategies The interaction between PD-1 and PD-L1 promotes tumor immune evasion, but immune checkpoint inhibitors can reinvigorate the immune system. However, most pa...
会议类别：免疫学-单抗和双抗标题：兼具高效抗肿瘤活性和可接受安全性的新型 TROP2 靶向免疫刺激抗体偶联物 (ISAC)摘要号：2718展示形式：壁报时间：2024年4月8日（星期一）1:30 PM - 5:00 PM（当地时间）地点：Poster Section 6讲者：熊慧中博士 会议类别：免疫学-免疫调节（免疫激动剂或共刺激途径）标题：肿...
第115届AACR年会将于美国东部时间2024年4月5日至2024年4月10日在美国加州圣地亚哥举行。当地时间3月5日AACR官网披露摘要标题,【肿瘤资讯】为您精选肺癌领域相关重要临床研究进展。 Clinical Trials Plenary Session CTPL04-Biomarkers: Quantifying Pharm...
All proffered papers that are accepted for poster or oral presentation at the AACR Annual Meeting 2023must be presented in person.Posters will not be presented in electronic format, and remote minisymposium presentations will not be permitted. Presenters who are unable to travel to Orlando to pre...
All proffered papers that are accepted for poster or oral presentation at the AACR Annual Meeting 2023must be presented in person.Posters will not be presented in electronic format, and remote minisymposium presentations will not be permitted. Presenters who are unable to travel to Orlando to pre...
Location: Poster Section 17 Poster Board Number: 14 Application ofMSDon the lung cancer associated idiopathic pulmonary fibros Presenter: Wen-Jen Yu Time: Sunday Apr 7 2024 1:30 PM - 5:00 M Location: Poster Section 4 Poster Board Number: 11 ...
Poster Number: CT051 Date: Monday, April 8, 2024 Candidate: BNT324/DB-1311 Session Title:Phase I Clinical Trials in Progress 2 Abstract Title: “A phase 1/2a, multicenter, open-label, first-in-human study to assess the safety, tolerability, pharm...
在刚落幕的2024 AACR大会上,华东医药靶向 HPK1 PROTAC研究以POSTER展示,接下来更多创新成果即将亮相各大国际会议:口服HPK1小分子抑制剂HDM2004研究入选 2024-CIMT年会POSTER,迈华替尼Ⅲ期关键性临床研究(HDHY-MHTN-III-1907)阳性结果、口服PTPN2小分子抑制剂 HDM2010 研究分别入选2024 ASCO年会POSTER和摘要。
The Innovation作者在AACR大会Poster环节展示论文 论文链接:https://www.cell.com/the-innovation/fulltext/S2666-6758(24)00063-8 北京大学肿瘤医院季加孚教授受邀做大会报告 期刊简介 扫二维码 |关注期刊官微 The Innovation是一本由青年科学家与Cell Press于2020年共同创办的综合性英文学术期刊:向科学界展示鼓舞人心...
FOSTER CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced poster presentations on vebreltinib (APL-101) at the 2024 American...